PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-19.03%
Both yoy net incomes decline, with BB at -168.63%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
1.61%
Less D&A growth vs. BB's 60.61%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-83.45%
Negative yoy deferred tax while BB stands at 108.33%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
6.05%
Less SBC growth vs. BB's 21.43%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
130.75%
Slight usage while BB is negative at -877.78%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
200.20%
AR growth while BB is negative at -36.36%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-396.46%
Both reduce yoy inventory, with BB at -251.11%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-143.28%
Negative yoy AP while BB is 200.00%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-165.97%
Negative yoy usage while BB is 307.69%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
103.42%
Well above BB's 52.31%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-14.22%
Both yoy CFO lines are negative, with BB at -455.56%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
16.44%
CapEx growth well above BB's 18.18%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-64.41%
Both yoy lines negative, with BB at -75.00%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
-51.47%
Both yoy lines negative, with BB at -178.01%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
103.41%
We have some liquidation growth while BB is negative at -73.21%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
170.80%
Growth well above BB's 90.85%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
75.53%
Investing outflow well above BB's 76.37%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
-150.00%
We cut debt repayment yoy while BB is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
38.64%
Issuance growth of 38.64% while BB is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
-6.02%
We cut yoy buybacks while BB is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.